CHP may be an isolated skin disease or associated with systemic features such as fever, hepatosplenomegaly, liver dysfunction, pancytopenia, coagulopathy... According to clinical case studies, treatment of CHP were based on systemic glucorticoid combined with cyclosporine, supportive care, manage potental infection as well as screening for underlying malignancies.